Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PATRY: Peroperative Administration of Tranexamic Acid in Gastric Bypass to Reduce Haemorrhage
2024-513570-22-00Phase 3Authorised
- Sponsor
- Franciscus Gasthuis & Vlietland
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of tranexamic acid in class III obesity (2 arms), sponsored by Franciscus Gasthuis & Vlietland. Primary endpoint: Postoperative intervention due to haemorrhage. Planned start May 2024; status: authorised.
02
Drugs
tranexamic acid
03
Conditions
class III obesity
Beyond the preview
Go deeper on 2024-513570-22-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-513570-22-00.